Scott & Selber Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,706
Closed -$2.44M 91
2024
Q2
$2.44M Sell
58,706
-24,551
-29% -$1.1M 0.78% 39
2024
Q1
$4.51M Sell
83,257
-1,463
-2% -$74.5K 1.54% 17
2023
Q4
$4.35M Sell
84,720
-6,638
-7% -$348K 1.63% 15
2023
Q3
$5.3M Sell
91,358
-872
-0.9% -$53.4K 2.19% 7
2023
Q2
$5.9M Sell
92,230
-192
-0.2% -$12.9K 2.31% 7
2023
Q1
$6.41M Buy
92,422
+101
+0.1% +$7.12K 2.73% 4
2022
Q4
$6.64M Sell
92,321
-66
-0.1% -$4.98K 2.99% 3
2022
Q3
$6.57M Buy
92,387
+384
+0.4% +$27.9K 3.16% 5
2022
Q2
$7.08M Sell
92,003
-464
-0.5% -$35.3K 3.23% 4
2022
Q1
$6.75M Sell
92,467
-3,020
-3% -$203K 2.6% 5
2021
Q4
$5.95M Buy
95,487
+13,775
+17% +$808K 2.11% 7
2021
Q3
$4.83M Buy
81,712
+46,636
+133% +$3.07M 1.96% 8
2021
Q2
$2.34M Buy
35,076
+17,428
+99% +$1.14M 0.9% 29
2021
Q1
$1.11M Buy
+17,648
New +$1.1M 0.46% 84
2020
Q4
Sell
-28,897
Closed -$1.74M 101
2020
Q3
$1.74M Buy
28,897
+331
+1% +$19.9K 0.78% 55
2020
Q2
$1.68M Sell
28,566
-362
-1% -$21.7K 0.83% 52
2020
Q1
$1.61M Buy
28,928
+197
+0.7% +$12K 1.01% 47
2019
Q4
$1.84M Buy
+28,731
New +$1.65M 0.87% 53

Other funds holding BMY

Scott & Selber Inc's BMY Position: Q3 2024 in Review

Scott & Selber Inc sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 58,706 shares — an estimated $2.44M sold.

Scott & Selber Inc first reported a position in BMY in Q4 2019 and held it in 18 quarters. The position peaked at $7.08M in Q2 2022. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Scott & Selber Inc reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Scott & Selber Inc sold 58,706 Bristol-Myers Squibb shares in Q3 2024, an estimated $2.44M.
  • Scott & Selber Inc first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 18 quarters.
  • Scott & Selber Inc's Bristol-Myers Squibb position peaked at $7.08M in Q2 2022.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Scott & Selber Inc's 13F filing for Q3 2024, filed 1 Nov 2024.